• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度西部新冠病毒病危重症患者的初步经验:病例系列

Initial Experience of Critically Ill Patients with COVID-19 in Western India: A Case Series.

作者信息

Shukla Urvi, Chavali Siddharth, Mukta Prashant, Mapari Amol, Vyas Anjali

机构信息

Department of Intensive Care, Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed) University, Lavale, Pune, Maharashtra, India.

Department of Neurosciences, Aditya Birla Memorial Hospital, Chinchwad, Maharashtra, India.

出版信息

Indian J Crit Care Med. 2020 Jul;24(7):509-513. doi: 10.5005/jp-journals-10071-23477.

DOI:10.5005/jp-journals-10071-23477
PMID:32963432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7482330/
Abstract

BACKGROUND

The novel coronavirus, named SARS-CoV-2, was first described in December 2019 as a cluster of pneumonia cases in Wuhan, China. It has since been declared a pandemic, with substantial mortality.

MATERIALS AND METHODS

In our case series, we describe the clinical presentation, characteristics, and outcomes of our initial experience of managing 24 critically ill COVID-19 patients at a designated COVID-19 ICU in Western India.

RESULTS

Median age of the patients was 54 years, and 58% were males. All patients presented with moderate to severe acute respiratory distress syndrome (ARDS); however, only 37.5% failed trials of awake proning and required mechanical ventilation. Patients who received mechanical ventilation typically matched the H-phenotype of COVID-19 pneumonia, and 55.5% of these patients were successfully extubated.

CONCLUSION

The most common reason for ICU admission in our series of 24 patients with severe COVID-19 was hypoxemic respiratory failure, which responded well to conservative measures such as awake proning and oxygen supplementation. Mortality in our case series was 16.7%.

HOW TO CITE THIS ARTICLE

Shukla U, Chavali S, Mukta P, Mapari A, Vyas A. Initial Experience of Critically Ill Patients with COVID-19 in Western India: A Case Series. Indian J Crit Care Med 2020;24(7):509-513.

摘要

背景

新型冠状病毒,名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2),于2019年12月首次在中国武汉作为一组肺炎病例被描述。此后它被宣布为大流行病,造成了大量死亡。

材料与方法

在我们的病例系列中,我们描述了在印度西部一家指定的新冠肺炎重症监护病房管理24例危重新冠肺炎患者的初始经验,包括临床表现、特征和结果。

结果

患者的中位年龄为54岁,58%为男性。所有患者均表现为中度至重度急性呼吸窘迫综合征(ARDS);然而,只有37.5%的患者清醒俯卧位试验失败并需要机械通气。接受机械通气的患者通常符合新冠肺炎肺炎的H表型,其中55.5%的患者成功拔管。

结论

在我们这组24例重症新冠肺炎患者中,入住重症监护病房的最常见原因是低氧性呼吸衰竭,其对清醒俯卧位和补充氧气等保守措施反应良好。我们病例系列中的死亡率为16.7%。

如何引用本文

舒克拉U、查瓦利S、穆克塔P、马帕里A、维亚斯A。印度西部危重新冠肺炎患者的初始经验:病例系列。《印度重症监护医学杂志》2020年;24(7):509 - 513。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb36/7482330/de42b37a0baa/ijccm-24-509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb36/7482330/7e3ab4abe7b5/ijccm-24-509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb36/7482330/de42b37a0baa/ijccm-24-509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb36/7482330/7e3ab4abe7b5/ijccm-24-509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb36/7482330/de42b37a0baa/ijccm-24-509-g002.jpg

相似文献

1
Initial Experience of Critically Ill Patients with COVID-19 in Western India: A Case Series.印度西部新冠病毒病危重症患者的初步经验:病例系列
Indian J Crit Care Med. 2020 Jul;24(7):509-513. doi: 10.5005/jp-journals-10071-23477.
2
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.
3
Awake Proning: Current Evidence and Practical Considerations.清醒俯卧位:当前证据与实际考量
Indian J Crit Care Med. 2020 Dec;24(12):1236-1241. doi: 10.5005/jp-journals-10071-23684.
4
Awake Prone Positioning in COVID-19 Patients.COVID-19患者的清醒俯卧位通气
Indian J Crit Care Med. 2020 Oct;24(10):914-918. doi: 10.5005/jp-journals-10071-23546.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
7
Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19-A Retrospective Study.新冠重症患者重症监护病房心脏骤停的特征与危险因素——一项回顾性研究
J Clin Med. 2021 May 19;10(10):2195. doi: 10.3390/jcm10102195.
8
Voluntary Prone Position for Acute Hypoxemic Respiratory Failure in Unintubated Patients.未插管患者急性低氧性呼吸衰竭的自愿俯卧位
Indian J Crit Care Med. 2020 Jul;24(7):557-562. doi: 10.5005/jp-journals-10071-23495.
9
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.围生期组织来源的间充质干细胞治疗危重症 COVID-19 诱导的 ARDS 患者:病例系列。
Stem Cell Res Ther. 2021 Jan 29;12(1):91. doi: 10.1186/s13287-021-02165-4.
10
Proning in Non-Intubated (PINI) in Times of COVID-19: Case Series and a Review.俯卧位通气(Non-Intubated,PINI)在 COVID-19 时期的应用:病例系列和综述。
J Intensive Care Med. 2020 Aug;35(8):818-824. doi: 10.1177/0885066620934801.

引用本文的文献

1
Reduction in the Rate of Mortality of Moderate to Severe COVID 19 Infected Patients with the use of Remdesivir - A Tertiary Care Hospital-Based Retrospective Observational Study.使用瑞德西韦降低中度至重度新冠病毒感染患者的死亡率——一项基于三级医疗医院的回顾性观察研究
Anesth Essays Res. 2022 Jul-Sep;16(3):296-300. doi: 10.4103/aer.aer_55_22. Epub 2022 Dec 9.
2
Predictive Value of Sequential Organ Failure Assessment, Quick Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II, and New Early Warning Signs Scores Estimate Mortality of COVID-19 Patients Requiring Intensive Care Unit.序贯器官衰竭评估、快速序贯器官衰竭评估、急性生理与慢性健康状况评分系统II以及新早期预警评分对入住重症监护病房的COVID-19患者死亡率的预测价值
Indian J Crit Care Med. 2022 Summer;26(4):464-471. doi: 10.5005/jp-journals-10071-24170.
3

本文引用的文献

1
Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience During the COVID-19 Pandemic.急诊科清醒、非插管患者早期自主翻身:COVID-19 大流行期间单一急诊科的经验。
Acad Emerg Med. 2020 May;27(5):375-378. doi: 10.1111/acem.13994.
2
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
3
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.2020 年印度因 COVID-19 直接健康影响导致的伤残调整生命年(DALYs)。
Sci Rep. 2022 Feb 14;12(1):2454. doi: 10.1038/s41598-022-06505-z.
4
Clinical Characteristics and Treatment Outcomes of 293 COVID-19 Patients Admitted to the Intensive Care Unit of a Tertiary Care Hospital of Eastern India.印度东部一家三级护理医院重症监护病房收治的293例新冠病毒病患者的临床特征及治疗结果
Indian J Crit Care Med. 2021 Dec;25(12):1395-1401. doi: 10.5005/jp-journals-10071-24048.
5
Effectiveness of remdesivir on hospital stay duration and mortality in patients with COVID-19 infection: A single-center retrospective observational study.瑞德西韦对新型冠状病毒肺炎感染患者住院时间和死亡率的疗效:一项单中心回顾性观察研究。
Lung India. 2022 Jan-Feb;39(1):85-88. doi: 10.4103/lungindia.lungindia_268_21.
6
Barotrauma, invasive ventilation, and timing of tocilizumab as predictors of mortality along with inflammatory markers and comorbidities in critically ill COVID-19 patients: A retrospective study.在危重症新型冠状病毒肺炎患者中,气压伤、有创通气、托珠单抗的使用时机作为死亡率的预测因素以及与炎症标志物和合并症的关系:一项回顾性研究
Indian J Anaesth. 2021 Oct;65(10):755-759. doi: 10.4103/ija.ija_637_21. Epub 2021 Oct 29.
7
A next generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia.一项用于揭示南亚地区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组和蛋白质组突变图谱的新一代测序(NGS)分析。
Curr Res Microb Sci. 2021 Aug 24;2:100065. doi: 10.1016/j.crmicr.2021.100065. eCollection 2021 Dec.
8
Epidemiology and clinical characteristics of COVID- 19 patients requiring critical care in a Tertiary care teaching hospital.三级护理教学医院中需要重症监护的新冠病毒病患者的流行病学及临床特征
J Anaesthesiol Clin Pharmacol. 2021 Jul-Sep;37(3):366-370. doi: 10.4103/joacp.JOACP_585_20. Epub 2021 Oct 12.
9
Awake Prone Positioning in the Management of COVID-19 Pneumonia: A Systematic Review.COVID-19肺炎管理中的清醒俯卧位:一项系统评价
Indian J Crit Care Med. 2021 Aug;25(8):896-905. doi: 10.5005/jp-journals-10071-23932.
10
Integrative management of critical case of Covid 19 with and modern medicine: A case report.中西医结合治疗新型冠状病毒肺炎危重症病例报告
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100496. doi: 10.1016/j.jaim.2021.07.012. Epub 2021 Jul 28.
新冠肺炎:针对不同表型采用不同的呼吸治疗方法?
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
4
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
5
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
6
Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province.通过早期识别和干预降低新冠病毒肺炎死亡率:来自江苏省的经验
Ann Intensive Care. 2020 Mar 18;10(1):33. doi: 10.1186/s13613-020-00650-2.
7
Coronavirus Disease 2019 (COVID-19) in Italy.意大利的2019冠状病毒病(COVID-19)。
JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.源自中国武汉的新型冠状病毒:全球卫生治理面临的挑战
JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.